ADVERTISEMENT
Union Budget 2026: Rs 10,000 crore investment in biopharma over next 5 years, says FM Nirmala SitharamanBiopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.
PTI
Last Updated IST
<div class="paragraphs"><p>Finance Minister Nirmala Sitharaman presents the 'Union Budget 2026-27' in the Lok Sabha</p></div>

Finance Minister Nirmala Sitharaman presents the 'Union Budget 2026-27' in the Lok Sabha

Credit: PTI photo

New Delhi: Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country's pharmaceuticals industry.

ADVERTISEMENT

Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.

Track live updates of Union Budget here

She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.

The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).

The India Semiconductor Mission (ISM) is a specialized, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem.

Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities.

She added that 'Sabka Saath, Sabka Vikas' is the third Kartavya of the government.

ADVERTISEMENT
(Published 01 February 2026, 11:36 IST)